About Dipna Pharmachem Limited
Data last updated: 05 January 2026
Dipna Pharmachem Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in chemical distribution and retail, a part of the broader chemicals and materials sector. Incorporated on 19 July 2011, the company has been in operation for over 15 years.
Registered with ROC Ahmedabad under CIN L24100GJ2011PLC066400. Listed.
Capital: an authorised share capital of ₹28.5 Cr and a paid-up capital of ₹26.29 Cr. Formerly known as Dipan Pharmachem Private Limited and Dipna Pharmachem Private Limited. It is led by directors including Nandish Shaileshbhai Jani and Parin Shirishkumar Bhavsar.
Last AGM: 30 August 2025. Financial statements filed for year ended 31 March 2025. Office: A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba, Ahmedabad, Gujarat, India – 380055.
As per the financials filed for FY 2025, the company reported a revenue of ₹124.93 Cr, a decline of 24% compared to the previous year.
The company is associated with 1 brand - Dipna Pharmachem. As per MCA filings, the company has open charges of ₹11.38 Cr and satisfied charges of ₹4.2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dipnapharmachem.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressA/211 Siddhi Vinayak Complex Near D.A.V. School Makarba, Ahmedabad, Gujarat, India – 380055
-
IndustryChemicals and Materials, Chemical Distribution & Retail
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Dipna Pharmachem Limited
Dipna Pharmachem Limited has undergone 2 name changes throughout its history. The company was previously known as Dipan Pharmachem Private Limited, and Dipna Pharmachem Private Limited. The current legal name is Dipna Pharmachem Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Dipna Pharmachem Limited | Current |
| Dipan Pharmachem Private Limited | Previous |
| Dipna Pharmachem Private Limited | Previous |
CIN History of Dipna Pharmachem Limited
Dipna Pharmachem Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100GJ2011PLC066400, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100GJ2011PLC066400 | Current |
| U24100GJ2011PLC066400 | Previous |
| U24100GJ2011PTC066400 | Previous |
Associated Brands with Dipna Pharmachem Limited
Dipna Pharmachem Limited operates one associated brand: Dipna Pharmachem. These brands represent Dipna Pharmachem Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Distributor of pharmaceutical raw materials | dipnapharmachem.com |
Competitors & Alternatives of Dipna Pharmachem Limited
Brands and companies operating in the same space as Dipna Pharmachem Limited include Entero Healthcare, AmerisourceBergen, Keimed and 2 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Entero Healthcare
|
India's leading healthcare products distribution platform | Mumbai, India, India | 2018 |
AmerisourceBergen
|
Pharmaceutical distribution and supply chain services are provided globally. | Chesterbrook, United States, United States | 1985 |
Keimed
|
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | Hyderabad, India, India | 2000 |
Sandor Medicaids
|
Provider of medical equipment, devices, and drugs distribution services | Hyderabad, India, India | 1995 |
Mahaveer Medi Sales
|
Serves as a distributor of a wide range of pharmaceutical drugs. | Bengaluru, India, India | 2016 |
Business Activity of Dipna Pharmachem Limited
Dipna Pharmachem Limited is engaged in the principal business activity of trade, with detailed activities including retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | ********* |
Auditor Details of Dipna Pharmachem Limited
Dipna Pharmachem Limited is audited by Devadiya & Associates (ICAI peer reviewed, certificate valid till 2026-05-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Devadiya & Associates (ICAI peer reviewed, certificate valid till 2026-05-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Dipna Pharmachem Limited
Dipna Pharmachem Limited is currently managed by 6 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandish Shaileshbhai Jani | Director | 07 Sep 2022 | 3 Years 10 Months | Current |
|
Parin Shirishkumar Bhavsar
Also directs:
Dipna Pharmachem Limited, Chandrima Mercantiles Ltd
|
Director | 03 May 2025 | 1 Years 2 Months | Current |
| Dipna Keyur Shah | Director | 19 Jul 2011 | 14 Years 11 Months | Current |
|
Keyur Dipakkumar Shah
Also directs:
Dipna Pharmachem Limited, Dipan Pharmachem Private Limited, Dhara Pharmachem Private Limited and 2 more
|
Cfo | 03 May 2025 | 1 Years 2 Months | Current |
Financials of Dipna Pharmachem Limited FY 2026 filings available
Dipna Pharmachem Limited reported revenue of ₹129.08 Cr (up 3.34% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹129.08 Cr | ₹124.92 Cr | ₹164.34 Cr | ₹99.93 Cr |
| Other Income | ₹2.54 Lakh | ₹1.28 Lakh | ₹40,000 | ₹63,000 |
| Total Income | ₹129.11 Cr | ₹124.93 Cr | - | - |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹122.37 Cr | ₹103.78 Cr | ₹176.35 Cr | ₹108.13 Cr |
| Changes in Inventories | -₹14.89 Cr | ₹9.95 Cr | -₹18.44 Cr | -₹12.64 Cr |
| Employee Benefit Expense | ₹41.12 Lakh | ₹41.45 Lakh | ₹43.62 Lakh | ₹43.5 Lakh |
| Finance Costs | ₹1.46 Cr | ₹2.02 Cr | ₹2 Cr | ₹95.64 Lakh |
| Depreciation & Amortisation | ₹1.43 Lakh | - | - | - |
| Other Expenses | ₹16.19 Cr | ₹7.34 Cr | ₹2.56 Cr | ₹1.66 Cr |
| Total Expenses | ₹125.56 Cr | ₹123.51 Cr | ₹162.92 Cr | ₹98.55 Cr |
| Profit Before Exceptional Items & Tax | ₹3.54 Cr | - | - | - |
| Exceptional Items | ₹0 | - | - | - |
| Profit Before Tax | ₹3.54 Cr | ₹1.42 Cr | ₹1.42 Cr | ₹1.38 Cr |
| Total Tax Expense | ₹91.29 Lakh | ₹44.59 Lakh | ₹33.41 Lakh | ₹46.94 Lakh |
| Net Profit | ₹2.63 Cr | ₹97.41 Lakh | ₹1.09 Cr | ₹91.18 Lakh |
| Other Comprehensive Income | ₹0 | - | - | - |
| Total Comprehensive Income | ₹2.63 Cr | - | - | - |
| EBITDA (computed) | ₹5.02 Cr | - | - | - |
| Basic EPS | ₹1.00 | - | - | - |
| Diluted EPS | ₹1.00 | - | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹205.63 Cr | ₹132.38 Cr | ₹132.91 Cr | ₹77.56 Cr |
| Non-current Assets | ₹51.54 Cr | ₹4.87 Lakh | ₹3.97 Lakh | ₹4.02 Lakh |
| Current Assets | ₹154.09 Cr | ₹132.33 Cr | ₹132.87 Cr | ₹77.52 Cr |
| Property, Plant & Equipment | ₹7.23 Lakh | ₹4.59 Lakh | - | - |
| Inventories | ₹42.33 Cr | ₹27.43 Cr | ₹37.38 Cr | ₹18.94 Cr |
| Trade Receivables | ₹48 Cr | - | - | - |
| Cash & Equivalents | ₹86.3 Lakh | ₹42.57 Lakh | ₹13.88 Cr | ₹5.69 Cr |
| Equity (Net Worth) | ₹62.3 Cr | - | - | - |
| Equity Share Capital | ₹26.29 Cr | - | - | - |
| Borrowings (Non-current) | ₹10.1 Cr | - | - | - |
| Borrowings (Current) | ₹3.11 Cr | - | - | - |
| Total Debt (computed) | ₹13.21 Cr | - | - | - |
| Current Liabilities | ₹133.23 Cr | ₹85 Cr | ₹82.84 Cr | ₹39.02 Cr |
| Total Liabilities | ₹143.33 Cr | - | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | -₹18.32 Cr | -₹9.19 Cr | -₹5.42 Cr | -₹20.98 Cr |
| Investing Cash Flow | -₹4.07 Lakh | -₹2.01 Lakh | -₹1.46 Lakh | -₹1.01 Lakh |
| Financing Cash Flow | ₹18.8 Cr | -₹4.24 Cr | ₹13.62 Cr | ₹26.47 Cr |
| Capital Expenditure | ₹4.07 Lakh | ₹2.01 Lakh | - | - |
| Free Cash Flow (computed) | -₹18.36 Cr | -₹9.21 Cr | - | - |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹43.73 Lakh | -₹13.45 Cr | ₹8.19 Cr | ₹5.48 Cr |
| Metrics | Q4 FY26 |
|---|---|
| Revenue from Operations | ₹2.02 Cr |
| Other Income | ₹2.54 Lakh |
| Total Income | ₹2.05 Cr |
| Cost of Materials Consumed | ₹0 |
| Purchases of Stock-in-Trade | ₹13.54 Cr |
| Changes in Inventories | -₹15.43 Cr |
| Employee Benefit Expense | ₹10.37 Lakh |
| Finance Costs | ₹23.14 Lakh |
| Depreciation & Amortisation | ₹44,000 |
| Other Expenses | ₹3.37 Cr |
| Total Expenses | ₹1.83 Cr |
| Profit Before Exceptional Items & Tax | ₹22.28 Lakh |
| Exceptional Items | ₹0 |
| Profit Before Tax | ₹22.28 Lakh |
| Total Tax Expense | ₹4.42 Lakh |
| Net Profit | ₹17.86 Lakh |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | ₹17.86 Lakh |
| EBITDA (computed) | ₹45.86 Lakh |
| Basic EPS | ₹0.07 |
| Diluted EPS | ₹0.07 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Chemicals Segment | ₹2.02 Cr | -₹61.08 Lakh | ₹40.81 Cr | ₹89.36 Cr |
| Steel Segment | ₹0 | ₹83.36 Lakh | ₹7.19 Cr | ₹20.98 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Chemicals Segment | ₹58.19 Cr | -₹5.12 Cr | - | - |
| Steel Segment | ₹70.89 Cr | ₹8.67 Cr | - | - |
Shareholding Pattern of Dipna Pharmachem Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 9.13%, retail and other public shareholders hold 90.87% of Dipna Pharmachem Limited. The company had 1,717 shareholders on record.
| Mar 2026 | Sep 2025 | Mar 2025 | Sep 2024 | Mar 2024 | Sep 2023 | |
|---|---|---|---|---|---|---|
| Promoters | 9.13% | 9.98% | 9.98% | 9.98% | 9.98% | 57.19% |
| Public | 90.87% | 90.02% | 90.02% | 90.02% | 90.02% | 42.81% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Promoters | 9.13% | 9.98% | 9.98% | 66.56% |
| Public | 90.87% | 90.02% | 90.02% | 33.44% |
| Promoter change (YoY, %pts) | -0.85 | +0.00 | -56.58 | - |
Charges & Borrowings of Dipna Pharmachem Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2022 | Others | ₹9 Cr | Open |
| 29 Oct 2022 | Others | ₹23 Lakh | Open |
| 09 Jun 2021 | Others | ₹2.15 Cr | Open |
| 07 Aug 2020 | Others | ₹35.49 Lakh | Satisfied |
| 18 Sep 2015 | Others | ₹2.85 Cr | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Dipna Pharmachem Limited
View historical data on people associated with Dipna Pharmachem Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Dipna Pharmachem Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Dipna Pharmachem Limited
GSTIN & GST Filing Data of Dipna Pharmachem Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Dipna Pharmachem Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Dipna Pharmachem Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Dipna Pharmachem Limited
MSME Payment Delays by Dipna Pharmachem Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Dipna Pharmachem Limited
Subsidiaries & Group Companies of Dipna Pharmachem Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Dipna Pharmachem Limited with ownership details.
MCA Filings & Documents of Dipna Pharmachem Limited
MCA Filings & Documents of Dipna Pharmachem Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Dipna Pharmachem Limited
Frequently Asked Questions about Dipna Pharmachem Limited
Dipna Pharmachem Limited is an active public limited company in the chemicals and materials sector based in Ahmedabad, Gujarat, India. It was incorporated on 19 July 2011 (15+ years old) and is registered under CIN L24100GJ2011PLC066400.
Dipna Pharmachem Limited reported revenue of ₹124.93 Cr for FY 2025 (down 24.00% YoY).
The current directors of Dipna Pharmachem Limited are:
- Nandish Shaileshbhai Jani
- Parin Shirishkumar Bhavsar
- Dipna Keyur Shah
- Keyur Dipakkumar Shah
- Madhuri Vijaykumar Gurwani
- Keyur Dipakkumar Shah
The primary industry of Dipna Pharmachem Limited is chemicals and materials. The company specifically operates in chemical distribution and retail. The company is currently active in this sector.
Yes, Dipna Pharmachem Limited is a listed company.
Dipna Pharmachem Limited can be reached at the registered office: A211 Siddhi Vinayak Complex Near D.A.V. School Makarba, Ahmedabad, Gujarat, India – 380055, or through the website dipnapharmachem.com.